Previous exercises

You can find out about our previous exercises where we have involved residents and partners in our work by selecting the links below. We also publish case studies of how we use your views to inform our work.

Patient participation group event

Date Exercise Ended - Tuesday, November 12, 2019

Your invitation to come along to this free information event on Tuesday, 12 November to find out more about your GP practice’s patient participation group and how you can get involved.

Shaping Sefton II - give your views

Date Exercise Ended - Monday, October 21, 2019

We are looking for views from our patients to help shape the future of healthcare in Sefton. Shaping Sefton II is our five year plan for working in a more joined up way across local health and care partners so that patients can get the right support and treatment first time, to help them live a healthy life and improve their wellbeing.

Review of local health policies – phase 3

Date Exercise Ended - Sunday, July 14, 2019

The latest phase of our project to review more than 100 health polices has begun and we are asking for your views to help make sure our limited NHS resources are used on the most effective treatments.

Public invited to comment on merger of two Liverpool hospital trusts

Date Exercise Ended - Thursday, June 13, 2019

A series of public events have been announced where people can share their views on the proposed merger of Aintree University Hospital NHS Foundation Trust and the Royal Liverpool and Broadgreen University Hospitals NHS Trust.

Developing our Patient Participation Groups

Date Exercise Ended - Wednesday, May 15, 2019

We started working with Healthwatch Sefton in 2019 to explore how we might support GP practices to develop their Patient Participation Groups (PPGs).

National consultation on the prescribing of low priority items

Date Exercise Ended - Thursday, February 28, 2019

NHS England (NHSE) and NHS Clinical Commissioners (NHSCC) have launched a new consultation to support the review of eight items currently available on prescription, which are considered to be of low clinical priority and which cost the NHS more than £68 million per year.